Skip to content
lifestyle.fictiontalk.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biovica International
Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Biovica International AB – Annual Report for The Financial Year 2025/2026 Published
June 30, 2026
Year-End Report 2025-2026
June 17, 2026
Biovica Receives Expanded Work Order from Clinical-Stage Oncology Company for Next-Generation CDK Inhibitor Program
May 26, 2026
Biovica International AB Announces Change in Executive Management
May 5, 2026
New ESMO Data Highlights TKa Across Multiple Treatment Settings
April 30, 2026
Theis Kipling New CEO for Biovica
April 7, 2026
Biovica International AB – Q3 Interim Report Nov 2025-Jan2026
March 18, 2026
New AACR Data Expand Evidence for TKa In Immunotherapy-Treated Patients and CDK Inhibitor Dose Optimization
March 18, 2026
Nomination Committee for Biovica International AB for the 2026 Annual General Meeting
March 9, 2026
←
Previous Page
1
2
3
Next Page
→